1. Home
  2. KVYO vs MMED Comparison

KVYO vs MMED Comparison

Compare KVYO & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Klaviyo Inc. Series A

KVYO

Klaviyo Inc. Series A

HOLD

Current Price

$15.02

Market Cap

4.3B

Sector

N/A

ML Signal

HOLD

MMED

MiniMed Group Inc. Common Stock

N/A

Current Price

$10.98

Market Cap

4.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KVYO
MMED
Founded
2012
1983
Country
United States
United States
Employees
2368
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
4.1B
IPO Year
2023
2026

Fundamental Metrics

Financial Performance
Metric
KVYO
MMED
Price
$15.02
$10.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
21
10
Target Price
$34.48
$22.56
AVG Volume (30 Days)
6.1M
582.9K
Earning Date
05-05-2026
06-03-2026
Dividend Yield
N/A
N/A
EPS Growth
35.29
N/A
EPS
0.03
N/A
Revenue
$1,234,019,000.00
N/A
Revenue This Year
$24.47
$15.99
Revenue Next Year
$19.66
$10.00
P/E Ratio
$485.83
N/A
Revenue Growth
31.63
N/A
52 Week Low
$13.53
$10.65
52 Week High
$36.76
$17.86

Technical Indicators

Market Signals
Indicator
KVYO
MMED
Relative Strength Index (RSI) 38.30 33.75
Support Level N/A N/A
Resistance Level $21.34 $15.80
Average True Range (ATR) 1.13 0.69
MACD -0.41 -0.01
Stochastic Oscillator 14.91 16.75

Price Performance

Historical Comparison
KVYO
MMED

About KVYO Klaviyo Inc. Series A

Klaviyo Inc is a technology company that provides a software-as-a-service (SaaS) platform to enable its customers to send the right messages at the right time across email, short message service, and push notifications, more accurately measure and predict performance, and deploy specific actions and campaigns. The platform combines proprietary data and application layers into one solution with machine learning and artificial intelligence capabilities. It is focused on marketing automation within eCommerce as its first application use case. It generates revenue through the sale of subscriptions to its customers for the use of its platform. Geographically, the company generates the majority of its revenue from the Americas, followed by EMEA and APAC.

About MMED MiniMed Group Inc. Common Stock

Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.

Share on Social Networks: